基本信息
浏览量:188
职业迁徙
个人简介
In atrial fibrillation, Prof. Pappone has established a fundamental role of catheter ablation in the treatment of patients, developing “the Pappone approach”, a method now accepted worldwide. Subsequently, he identified the “rotors” as responsible for the persistence of atrial fibrillation and as a target of radiofrequency ablation, clarifying the anatomical and functional bases of this complex and common cardiac arrhythmia.
In heart failure, Prof. Pappone developed and used cardiac resynchronization therapy using innovative multipolar catheters in patients with refractory heart failure.
In Wolff-Parkinson-White Syndrome (WPW), he carried out pioneering studies demonstrating the possibility of identifying asymptomatic WPW patients at high risk of malignant arrhythmias. These results generated new recommendations in the guidelines, leading to treatment by ablation in asymptomatic patients with accessory pathways at risk of sudden death.
In Brugada Syndrome, he identified and characterized for the first time the arrhythmic substrate in affected patients, and was the first in the world to devise and develop an innovative epicardial ablation of the arrhythmic substrate, which drastically reduces the occurrence of malignant arrhythmias in patients at risk of sudden death. To date, more than 600 patients suffering from Brugada syndrome have been subjected to ablation of the arrhythmic substrate, with the disappearance of the Brugada pattern and malignant ventricular arrhythmias in almost all cases.
In heart failure, Prof. Pappone developed and used cardiac resynchronization therapy using innovative multipolar catheters in patients with refractory heart failure.
In Wolff-Parkinson-White Syndrome (WPW), he carried out pioneering studies demonstrating the possibility of identifying asymptomatic WPW patients at high risk of malignant arrhythmias. These results generated new recommendations in the guidelines, leading to treatment by ablation in asymptomatic patients with accessory pathways at risk of sudden death.
In Brugada Syndrome, he identified and characterized for the first time the arrhythmic substrate in affected patients, and was the first in the world to devise and develop an innovative epicardial ablation of the arrhythmic substrate, which drastically reduces the occurrence of malignant arrhythmias in patients at risk of sudden death. To date, more than 600 patients suffering from Brugada syndrome have been subjected to ablation of the arrhythmic substrate, with the disappearance of the Brugada pattern and malignant ventricular arrhythmias in almost all cases.
研究兴趣
论文共 543 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
HEARTno. 4 (2024): 235-244
European Heart Journal Supplementsno. Supplement_1 (2024)
Giovanni Peretto,Emanuele Micaglio,Giuseppe Ciconte, Marianna Maia, Martina Luzzi, Marianna Cariello, Adele Gabriella Rosa Bonfanti,Davide Lazzeroni, Luigi Anastasia, Paolo Cavoretto,Alaide Chieffo,Paolo Della Bella,
Frontiers in cardiovascular medicine (2024): 1362692-1362692
Giovanni Peretto,Giovanni Peretto,Giovanni Peretto,Emanuele Micaglio,Giuseppe Ciconte,Giuseppe Ciconte, Marianna Maia, Martina Luzzi, Marianna Cariello, Adele Gabriella Rosa Bonfanti,Davide Lazzeroni,Luigi Anastasia,
Frontiers in Cardiovascular Medicine (2024)
Frontiers in cardiovascular medicine (2023): 1110392
引用0浏览0WOS引用
0
0
European heart journal. Digital healthno. 6 (2023): 473-487
International Journal of Molecular Sciencesno. 7 (2023): 6687-6687
Heart Rhythmno. 9 (2023): e145-e146
引用0浏览0引用
0
0
Carlo Gaspardone,Davide Romagnolo,Alessandro Fasolino,Giulio Falasconi,Alessandro Beneduce,Giorgio Fiore, Emma Didelon, Fabrizio Fortunato,Carmine Galdieri, Giuseppe Antonio Posteraro,Giacomo Ingallina,Francesco Ancona,
AMERICAN HEART JOURNAL (2023): 94-105
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn